Table 4.
Characteristics | Univariate analysis of DFS | Multivariate analysis of DFS | ||||
---|---|---|---|---|---|---|
Hazard ratio | 95% CI | p-value | Hazard ratio | 95% CI | p-value | |
Age (> 62 vs. ≤62) | 1.251 | 0.725 - 2.158 | 0.420 | |||
Sex (female vs male) | 1.005 | 0.544 - 1.856 | 0.987 | |||
Advanced T stage (pT4 vs. pT2/3) | 7.564 | 2.356 – 24.286 | 0.001 | 6.569 | 2.014 – 21.422 | < 0.001 |
Advanced N stage (pN2/3 vs. pN0/1) | 3.544 | 1.959 – 6.409 | < 0.001 | 2.500 | 1.359 – 4.601 | 0.003 |
Lauren’s classification (diffuse vs. non-diffuse) | 1.255 | 0.680 - 2.317 | 0.467 | |||
Venous invasion (yes vs. no) | 1.940 | 0.771 - 4.883 | 0.159 | |||
Tumor grade (poor vs well to moderate) | 1.172 | 0.626 – 2.197 | 0.619 | |||
Adjuvant chemotherapy (yes vs. no) | 1.196 | 0.687– 2.083 | 0.526 | |||
High DKK1 (yes vs. no) | 2.497 | 1.421 – 4.386 | 0.001 | 2.092 | 1.180 – 3.708 | 0.012 |
Univariate analysis of OS | Multivariate analysis OS | |||||
1.934 | 1.269 - 2.946 | 0.002 | 1.820 | 1.189-2.785 | 0.006 | |
0.656 | 0.403 - 1.069 | 0.091 | ||||
3.356 | 1.825 - 6.170 | < 0.001 | 3.137 | 1.674 – 5.879 | < 0.001 | |
2.174 | 1.431 - 3.302 | < 0.001 | 1.661 | 1.074 – 2.568 | 0.023 | |
1.073 | 0.690 - 1.668 | 0.755 | ||||
1.763 | 0.852 - 3.649 | 0.126 | ||||
1.058 | 0.671 - 1.668 | 0.808 | ||||
0.898 | 0.596 - 1.355 | 0.610 | ||||
2.509 | 1.637 – 3.846 | < 0.001 | 2.130 | 1.370 – 3.312 | 0.001 |